Autobio third quarter report of 2021 shows that in the first three quarters of this year, it achieved salse of CNY 2.695 billion, up 31.64% year on year. Autobio q3 net profit was CNY 717 million, up 39.33% year-on-year.

The US Food and Drug Administration last week granted Emergency Use Authorization for InBios International's SCoV-2 Detect Neutralizing Ab ELISA immunoassay for SARS-CoV-2.

People at risk from strokes and heart attacks could benefit from personalised clotting profiles to help clinicians prescribe more precise treatments, thanks to new research.

As a leading company of immunoassay solutions, YHLO’s core products have gained recognition from professionals in the field. Top Chinese hospitals including Fuwai Hospital, Peking Union Medical College Hospital (PUMCH), Beijing Hospital and more have been cooperating with YHLO for years.

Amazon Care will be rolled out in additional cities in 2021, including Dallas, Chicago, Philadelphia, Boston and Los Angeles "just to name a few," Kristen Helton, the director of Amazon Care, said at the annual HLTH conference on Tuesday.

Genetron Health said Friday that it has entered into an exclusive agreement with Jiangsu Fosun Pharmaceutical Sales, a subsidiary of Shanghai Fosun Pharmaceutical, to commercialize its minimal residual disease assay Seq-MRD.

Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections.

Total sales growth of 10.7% to $23.3 Billion with operational growth of 9.9%* and adjusted operational growth of 10.6%. Earnings per share of $1.37 increasing 3.0% and adjusted earnings per share of $2.60 increasing 18.2%.

MDxHealth reported on Thursday that its third quarter revenues rose 23 percent year over year, largely due to a 23 percent increase in services revenues during the quarter.

Danaher on Thursday reported a 23 percent year-over-year increase in third quarter revenues, which included a rise of nearly 25 percent in life sciences revenues and of nearly 30 percent in diagnostics revenues.

BioMérieux reported on Thursday that its third quarter revenues grew 11 percent year over year, driven by growth across its application areas.

Cell fitness has been identified as a way of predicting health outcomes in COVID patients, according to a University of Queensland study.

Abbott reported Wednesday that its third quarter Diagnostics business revenues rose 48 percent year over year, mainly driven by sales in its Core Laboratory and Rapid Diagnostics businesses.

Roche said on Wednesday that its diagnostics division revenues grew 38 percent year over year, or 39 percent at constant exchange rates, in the first nine months of 2021, due to high demand for COVID-19 tests, recovery in the base business, and the launch of new diagnostic platforms.

October 19, 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (“Mindray”) (300760.SZ) released the third quarter report: sale in the third quarter was 6.613 billion CNY, up 20.25% year on year.